Tri-Valley Clinic
Tri-Valley Clinic · 680 MOWRY AVE · Fremont, CA 94536
5.0· 21 Google reviews
Listing updated October 2, 2026
Quick facts
- Address
- 680 MOWRY AVE, Fremont, CA 94536
- Phone
- (510) 598-4921
- Website
- trivalleyclinic.com
- Hours (per its website)
- Mon,Tue,Wed,Thu,Fri 09:30-17:30
- Telehealth
- Yes
- FDA-approved GLP-1 medications listed
- None listed on its website
- Accepting new patients (per website)
- Yes
- Google rating
- ★5.0 from 21 reviews
- Patient sentiment
- 100% positive, 0% negative (21 reviews analyzed)
- Most praised
- Friendly, helpful staff (11 reviews)
- Most common complaint
- None recurring
- Social profiles
- Retatrutide
- Not yet available anywhere — investigational, not FDA-approved
- Listing last updated
- October 2, 2026
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Tri-Valley Clinic is a telehealth psychiatry practice in Fremont, California, with a page describing a GLP-1 weight-loss program. Its website introduces Dr. Shabeg Gondara, MD, as its president, a physician specializing in psychiatry, and offers booking with Dr. Japsharan Gill, MD; care is delivered by secure video to patients anywhere in California, and the weight program begins with a medical evaluation to decide whether GLP-1 therapy is appropriate. On Google it has a 5.0-star rating across 21 reviews, all from 2026, and reviewers most often mention the staff, with 3 each mentioning knowledge, a caring approach and scheduling.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | — |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-18. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 21 Google reviews. Of the 21 reviews we analyzed, 21 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Friendly, helpful staff11 reviews
- Knowledgeable, professional providers3 reviews
- Feeling listened to3 reviews
- Easy scheduling and communication3 reviews
Common complaints
No negative reviews among those we analyzed.
Most recent Google reviews
Dlg G.★★★★★2026-08-27The doctors here are AWESOME. And the front desk staff is a wonderful person!!!
Qinwu X.★★★★★2026-08-26I met Dr. Gondara, he is very professional and silled and sympathic, the front desk is very friendly. I highly recommended!
Consuelo B.★★★★★2026-08-12Our first visit with Dr Gill was great. My 4 clients were so pleased and happy to talk with the doctor. Veronica at your front office was pleasant and friendly, my clients feel at eased and comfortable. We look forward to a long patient/doctor relationship.
Ken G.★★★★★2026-07-24Very attentive, Non judgmental and very relaxed atmosphere
Antonisha B.★★★★★2026-07-04This place is amazing and the people who works here are so welcoming.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Fremont
True Form Medical Group
39180 Farwell Drive · Fremont, CA 94538
4.6(18 Google reviews · 3 in past year)
The Space Aesthetics Center
1860 Mowry Avenue · Fremont, CA 94538
5.0(76 Google reviews · 34 in past year)
RenewMD Beauty and Wellness
5657 Auto Mall Parkway · Fremont, CA 94538
4.6(176 Google reviews · 43 in past year)
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs